antimony has been researched along with Torsade de Pointes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ficker, E; Kuryshev, YA; Wan, X; Wang, L; Wible, BA | 1 |
| Alcázar, R; Benezet, J; De la Torre, M; Ortega-Carnicer, J | 1 |
| Atienza Fernández, F; Castelló Viguer, MT; Cuesta Estellés, G; Echánove Errazti, I; Esteban Esteban, E; Ridocci Soriano, F | 1 |
3 other study(ies) available for antimony and Torsade de Pointes
| Article | Year |
|---|---|
Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents.
Topics: Action Potentials; Antimony; Antiprotozoal Agents; Calcium; Cell Line; Ether-A-Go-Go Potassium Channels; Humans; Leishmaniasis, Visceral; Long QT Syndrome; Myocardium; Torsades de Pointes | 2006 |
Pentavalent antimonial-induced torsade de pointes.
Topics: Aged; Anti-Arrhythmia Agents; Antimony; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Torsades de Pointes | 1997 |
[Torsades de pointes during treatment of leishmaniasis with meglumine antimoniate].
Topics: Aged; Antimony; Antiprotozoal Agents; Electrocardiography; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Torsades de Pointes | 1999 |